202 related articles for article (PubMed ID: 12146015)
1. [Long-term side effects of chemotherapy for testicular cancer].
Kawai K
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1300-5. PubMed ID: 12146015
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of testicular and second cancer].
Kawai K; Akaza H
Gan To Kagaku Ryoho; 1999 Nov; 26(13):2021-8. PubMed ID: 10584566
[TBL] [Abstract][Full Text] [Related]
3. Serum creatinine and cholesterol levels of testicular cancer patients in long-term follow up.
Hisamatsu E; Kawai K; Hinotsu S; Miyanaga N; Shimazui T; Akaza H
Int J Urol; 2005 Aug; 12(8):751-6. PubMed ID: 16174050
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
Hohnloser JH; Schierl R; Hasford B; Emmerich B
Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
[TBL] [Abstract][Full Text] [Related]
5. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O;
Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037
[TBL] [Abstract][Full Text] [Related]
6. Editorial comment on: paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Salonia A
Eur Urol; 2010 Jul; 58(1):140-1. PubMed ID: 20395038
[No Abstract] [Full Text] [Related]
7. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
[TBL] [Abstract][Full Text] [Related]
8. Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damage.
de Vos FY; Nuver J; Willemse PH; van der Zee AG; Messerschmidt J; Burgerhof JG; de Vries EG; Gietema JA
Eur J Cancer; 2004 Mar; 40(5):696-700. PubMed ID: 15010070
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis.
von Schlippe M; Fowler CJ; Harland SJ
Br J Cancer; 2001 Sep; 85(6):823-6. PubMed ID: 11556831
[TBL] [Abstract][Full Text] [Related]
10. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
11. Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Sleijfer DT; van Gessel AI; van Roon AM; van der Meer J; van den Berg MP; Burgerhof JG; Hoekstra HJ; Sluiter WJ; Gietema JA
Eur J Cancer; 2004 Mar; 40(5):701-6. PubMed ID: 15010071
[TBL] [Abstract][Full Text] [Related]
12. [Thromboembolic complications during cisplatin-containing chemotherapy for testicular cancer: a problem in the short and possibly also the long term].
Nuver J; Gietema JA
Ned Tijdschr Geneeskd; 2003 Mar; 147(10):428-30. PubMed ID: 12666510
[TBL] [Abstract][Full Text] [Related]
13. History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.
Sweeney C
Semin Urol Oncol; 2001 Aug; 19(3):170-9. PubMed ID: 11561984
[TBL] [Abstract][Full Text] [Related]
14. Testicular sperm extraction in azoospermic patients with gonadal germ cell tumors prior to chemotherapy--a new therapy option.
Schrader M; Muller M; Straub B; Miller K
Asian J Androl; 2002 Mar; 4(1):9-15. PubMed ID: 11907623
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
Ishioka J; Fujii Y; Kageyama Y; Fukuda H; Higashi Y; Kihara K
Int J Urol; 2008 Jul; 15(7):642-5. PubMed ID: 18643784
[TBL] [Abstract][Full Text] [Related]
16. [Coronary heart disease and hypertension as late effects of testicular cancer treatment--a minireview].
Valentová M; Mladosievicová B
Klin Onkol; 2011; 24(1):18-22. PubMed ID: 21542272
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
18. Paternity following treatment for testicular cancer.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O
J Natl Cancer Inst; 2005 Nov; 97(21):1580-8. PubMed ID: 16264178
[TBL] [Abstract][Full Text] [Related]
19. Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer.
Schilsky RL; Barlock A; Ozols RF
Cancer Treat Rep; 1982 Sep; 66(9):1767-9. PubMed ID: 6889461
[TBL] [Abstract][Full Text] [Related]
20. Treatment of testicular cancer and the development of secondary malignancies.
Bokemeyer C; Schmoll HJ
J Clin Oncol; 1995 Jan; 13(1):283-92. PubMed ID: 7799032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
